Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Osteoblastoma D018215 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Drowning D004332 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Radiculopathy D011843 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Taylor L et al. Prostaglandin production by type II alveolar epithelial cells. 1979 Biochim. Biophys. Acta pmid:435506
Best LC et al. Lanthanum stimulates the accumulation of cyclic AMP and inhibits secretion and thromboxane B2 formation in human platelets. 1980 Biochim. Biophys. Acta pmid:6251913
Shaw JO et al. Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). 1981 Biochim. Biophys. Acta pmid:7213765
Wahle KW and Peacock LI Effects of isomeric cis and trans eighteen carbon monounsaturated fatty acids on porcine platelet function. 1996 Biochim. Biophys. Acta pmid:8652649
Teng CM et al. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom. 1984 Biochim. Biophys. Acta pmid:6426517
Kimura Y et al. Effects of stilbenes on arachidonate metabolism in leukocytes. 1985 Biochim. Biophys. Acta pmid:3922423
Bellan JA et al. Concentration-activity profile of the modulation of cyclooxygenase product formation by reduced glutathione in microsomal fractions from the goat lung. 1990 Biochim. Biophys. Acta pmid:2114178
Fischer S et al. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites. 1986 Biochim. Biophys. Acta pmid:3754157
Bartolini G et al. Regulation of thromboxane A2 biosynthesis in platelet-free human monocytes and the possible role of polypeptide growth factor(s) in the induction of cyclooxygenase system. 1986 Biochim. Biophys. Acta pmid:3085720
Grundfest CC et al. Acrolein: a potent modulator of lung macrophage arachidonic acid metabolism. 1982 Biochim. Biophys. Acta pmid:6814492
Aharony D et al. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. 1982 Biochim. Biophys. Acta pmid:6814496
Cathcart MC et al. Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer. 2014 Biochim. Biophys. Acta pmid:24480048
Geisel J et al. Endotoxin-induced arachidonic acid metabolism requires de novo protein synthesis and protein kinase C activation. 1991 Biochim. Biophys. Acta pmid:1909897
Cook-Johnson RJ et al. Endothelial cell COX-2 expression and activity in hypoxia. 2006 Biochim. Biophys. Acta pmid:17046322
Roberts LJ et al. Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. 1979 Biochim. Biophys. Acta pmid:389290
Fitzpatrick FA and Gorman RR A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors. 1978 Biochim. Biophys. Acta pmid:629996
Orlandi M et al. Thromboxane A2 synthase activity in platelet free human monocytes. 1994 Biochim. Biophys. Acta pmid:7811713
Truitt A et al. Antiplatelet effects of conjugated linoleic acid isomers. 1999 Biochim. Biophys. Acta pmid:10320806
Sato T et al. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process. 1987 Biochim. Biophys. Acta pmid:3663714
Fuse I and Tai HH Does protein kinase C activation mediate thrombin-induced arachidonate release in human platelets? 1988 Biochim. Biophys. Acta pmid:3140902
Huang TF et al. Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib. 1993 Biochim. Biophys. Acta pmid:8251530
Teng CM et al. Antiplatelet effect of butylidenephthalide. 1987 Biochim. Biophys. Acta pmid:3109495
Bottje W et al. Indomethacin attenuation of hepatic perfusion and plasma 6-ketoPGF1 alpha elevations following glutathione depletion in rabbits. 1991 Biochim. Biophys. Acta pmid:1991131
Ko FN et al. Antiplatelet effects of chelerythrine chloride isolated from Zanthoxylum simulans. 1990 Biochim. Biophys. Acta pmid:2162213
Croft KD et al. Onset of changes in phospholipid fatty acid composition and prostaglandin synthesis following dietary manipulation with n-6 and n-3 fatty acids in the rat. 1985 Biochim. Biophys. Acta pmid:3995069
Tsunomori M et al. 15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. 1996 Biochim. Biophys. Acta pmid:8679681
Mobley A et al. Selective inhibition of 5-lipoxygenase pathway in rat pulmonary alveolar macrophages by cigarette smoking. 1987 Biochim. Biophys. Acta pmid:3030439
Miller OV et al. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence. 1982 Biochim. Biophys. Acta pmid:6285985
Ko FN et al. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies. 1993 Biochim. Biophys. Acta pmid:8380343
Teng CM et al. Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng. 1989 Biochim. Biophys. Acta pmid:2923911
Hayashi Y et al. Enzyme immunoassay of thromboxane B2. 1983 Biochim. Biophys. Acta pmid:6407530
Elliott GR et al. Changes in resident rat peritoneal macrophage eicosanoid release, induced by altering the buffer K+/Na+ ratio, are Ca2+ dependent. 1985 Biochim. Biophys. Acta pmid:3933563
Turk J et al. Arachidonic acid metabolism in isolated pancreatic islets. I. Identification and quantitation of lipoxygenase and cyclooxygenase products. 1984 Biochim. Biophys. Acta pmid:6329307
Ciabattoni G et al. Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. 1987 Biochim. Biophys. Acta pmid:3567215
Robinson C et al. Thromboxane B2 uptake and metabolism in isolated perfused lung. Identification and comparison with prostaglandin F2 alpha. 1982 Biochim. Biophys. Acta pmid:6751406
Schafer AI et al. Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets. 1982 Biochim. Biophys. Acta pmid:6812645
Caprani A et al. Experimental evidence of a potentially increased thrombo-embolic disease risk by domestic electromagnetic field exposure. 2004 Bioelectromagnetics pmid:15114641
Bartolini G et al. Possible involvement of prostaglandin H synthase-1 induction in the differentiation of U-937 cells. 1995 Biofactors pmid:7546213
Wolfram RM et al. Salivary isoprostanes indicate increased oxidation injury in periodontitis with additional tobacco abuse. 2006 Biofactors pmid:17264390
Olszowski T et al. The Effect of Cadmium on COX-1 and COX-2 Gene, Protein Expression, and Enzymatic Activity in THP-1 Macrophages. 2015 Biol Trace Elem Res pmid:25645360
Korbecki J et al. Cyclooxygenase-1 as the main source of proinflammatory factors after sodium orthovanadate treatment. 2015 Biol Trace Elem Res pmid:25398544
Qu X et al. Selenium deficiency-induced alterations in the vascular system of the rat. 2000 Biol Trace Elem Res pmid:11051602
Knowles SO and Donaldson WE Lead disrupts eicosanoid metabolism, macrophage function, and disease resistance in birds. 1997 Oct-Nov Biol Trace Elem Res pmid:9404672
Tran-Thi TA et al. Output and effects of thromboxane produced by the liver perfused with phorbol myristate acetate. 1988 Biol. Chem. Hoppe-Seyler pmid:3242547
Redl H et al. The elastase-inhibitor eglin has no effect in an ovine model of endotoxemia. 1988 Biol. Chem. Hoppe-Seyler pmid:3060136
Ishibashi M et al. Analysis of 11-dehydrothromboxane B2 in human urine improved by use of gas chromatography/high-resolution selected ion monitoring with 18O2-labelled analogue as an internal standard. 1994 Biol. Mass Spectrom. pmid:7986831
Tanaka M et al. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats. 1997 Biol. Neonate pmid:9303217
Stuart MJ and Dusse J In vitro comparison of the efficacy of cyclooxygenase inhibitors on the adult versus neonatal platelet. 1985 Biol. Neonate pmid:4005330
Smalling WE et al. Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets. 2004 Biol. Neonate pmid:14981352
Osiovich H et al. Cardiopulmonary effects of tumor necrosis factor-alpha in the piglet: influence of cyclooxygenase inhibition. 1995 Biol. Neonate pmid:8835089
Zheng NX et al. Pharmacokinetic and pharmacodynamic studies of a thromboxane synthetase inhibitor, ozagrel, in rabbits. 1995 Biol. Pharm. Bull. pmid:8787798
Kim YJ Rhamnetin attenuates melanogenesis by suppressing oxidative stress and pro-inflammatory mediators. 2013 Biol. Pharm. Bull. pmid:23739488
Bermejo BP et al. Sesquiterpenes from Jasonia glutinosa: in vitro anti-inflammatory activity. 2002 Biol. Pharm. Bull. pmid:11824534
Togna AR et al. 4-Methylcoumarin derivatives with anti-inflammatory effects in activated microglial cells. 2014 Biol. Pharm. Bull. pmid:24389482
Katoh M et al. Inhibitory effects of TA-993 and its metabolite MB3 on platelet activation induced by collagen and U-46619 in human platelets. 2001 Biol. Pharm. Bull. pmid:11379769
Hsiao G et al. Antiplatelet action of 3',4'-diisovalerylkhellactone diester purified from Peucedanum japonicum Thunb. 1998 Biol. Pharm. Bull. pmid:9703250
Akagi Y et al. Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats. 2011 Biol. Pharm. Bull. pmid:21415533
Noguchi M et al. Enzymologic and pharmacologic profile of loxoprofen sodium and its metabolites. 2005 Biol. Pharm. Bull. pmid:16272692
Yokoyama H et al. Theoretical investigation of aspirin dosage regimen to exhibit optimal antiplatelet effects and decrease risk of upper gastrointestinal lesions. 2012 Biol. Pharm. Bull. pmid:23047244
Basselin M et al. Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain. 2007 Biol. Psychiatry pmid:17628508
Evans CA et al. Gestational changes in prostanoid concentrations in intrauterine tissues and fetal fluids from pregnant sheep, and the relation to prostanoid output in vitro. 1982 Biol. Reprod. pmid:6896829
Wilson L et al. Alterations in reproductive tissue prostaglandins E and F, 6-keto-prostaglandin F1 alpha and thromboxane B2 with gestational age in the rat. 1982 Biol. Reprod. pmid:6897617
Dubin NH et al. Thromboxane production in the pregnant rat: differential recovery by platelets and uterus following aspirin administration. 1983 Biol. Reprod. pmid:6626652
Miller JB et al. Alterations in plasma and tissue prostaglandin levels in rabbits during luteal regression. 1983 Biol. Reprod. pmid:6688954
Lei ZM et al. Expression of thromboxane A2 receptor gene and thromboxane A2 synthase in bovine corpora lutea. 1992 Biol. Reprod. pmid:1391329
Wilson L and Huang LS Contributions of the fetoplacental unit to augmented uterine prostaglandin levels periparturition in the rat. 1985 Biol. Reprod. pmid:3840391
Chou YI et al. Correlations of platelet-derived microparticles with thromboxane B2, platelet-activating factor, endothelin-1, and neutrophil to lymphocyte ratio in patients with coronary intermediate lesions. 2014 Biomarkers pmid:25391885
Lüdicke F et al. A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers. 2015 Biomarkers pmid:26616146
Burhop KE et al. Effects of intravenous infusions of diaspirin cross-linked hemoglobin (DCLHb) on sheep. 1992 Biomater Artif Cells Immobilization Biotechnol pmid:1391481
Hubbell JA and McIntire LV Visualization and analysis of mural thrombogenesis on collagen, polyurethane and nylon. 1986 Biomaterials pmid:3778995
Leake DL et al. Comparative study of the thromboresistance of Dacron combined with various polyurethanes. 1989 Biomaterials pmid:2529915
Cenni E et al. Platelet and coagulation factor variations induced in vitro by polyethylene terephthalate (Dacron) coated with pyrolytic carbon. 1995 Biomaterials pmid:8580259
Cenni E et al. Numerical and functional modifications in platelets induced by polyester coated by a hydrophilic polymer. 1993 Biomaterials pmid:8399951
Xie P et al. Antithrombotic Effect and Mechanism of Radix Paeoniae Rubra. 2017 Biomed Res Int pmid:28299338
Yan H et al. Seawater Immersion Aggravates Burn Injury Causing Severe Blood Coagulation Dysfunction. 2016 Biomed Res Int pmid:26885523
Abbas NA et al. Thromboxane plasma level in kappa-carrageenin-induced acronecrosis of the tail in rats. 1991 Biomed. Biochim. Acta pmid:1759973
Becker K et al. Influence of the specific antagonist of PAF-acether, BN 52021, and of Ginkgo extract on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB2. 1988 Biomed. Biochim. Acta pmid:3073760
Ito T et al. Selective thromboxane synthetase inhibitor and ischemic heart disease. 1984 Biomed. Biochim. Acta pmid:6542777
Block HU et al. Estimation of thromboxane B2 in the clotting human whole blood by gas chromatography. 1984 Biomed. Biochim. Acta pmid:6517904
Beitz A et al. Thromboxane B2 (TXB2) formation in clotting whole blood of healthy and diabetic humans in vitro. 1984 Biomed. Biochim. Acta pmid:6517908
Schaper U et al. Inhibition of lipoxygenase (LOX) or of cyclooxygenase (COX) improves survival of rats in endotoxin shock. 1988 Biomed. Biochim. Acta pmid:3150270
Giessler C et al. An enzyme-linked immunoassay for thromboxane B2 and 6-oxo-PGF1 alpha using peroxidase as label. 1988 Biomed. Biochim. Acta pmid:3248100
Heinroth-Hoffmann I et al. Effects of trapidil and trapidil derivatives on arachidonic acid and prostaglandin endoperoxide analogue U 46619-induced blood pressure changes in rats. 1988 Biomed. Biochim. Acta pmid:3248102
Vapaatalo H et al. Plasma catecholamines and production of thromboxane B2 by platelets after psychological and physical tests in normotensive and mild hypertensive subjects. 1988 Biomed. Biochim. Acta pmid:3248115
Lamers JM et al. Dietary fish oil reduces intimal proliferation of the coronary artery caused by implantation of a constrictor in pigs. 1988 Biomed. Biochim. Acta pmid:3248119
Shindo N et al. Rapid quantification of 11 prostanoids by combined capillary column gas chromatography and negative ion chemical ionization mass spectrometry: application to prostanoids released from normal human embryonic lung fibroblasts WI38 in a culture medium. 1988 Biomed. Environ. Mass Spectrom. pmid:3349205
Voyksner RD et al. Derivatization to improve thermospray HPLC/MS sensitivity for the determination of prostaglandins and thromboxane B2. 1987 Biomed. Environ. Mass Spectrom. pmid:2960399
Ishibashi M et al. Dimethylisopropylsilyl ether derivative in gas chromatography/mass spectrometry of 11-dehydrothromboxane B2. 1988 Biomed. Environ. Mass Spectrom. pmid:3191252
Li D et al. Diet rich in saturated fat decreases the ratio of thromboxane/prostacyclin in healthy men. 2003 Biomed. Environ. Sci. pmid:15011964
Mallen DN et al. Structural verification of 15-oxo-13,14-dihydrothromboxane B2. 1978 Biomed. Mass Spectrom. pmid:678616
Roselló J et al. Quantitative profiling of the metabolic cascade of arachidonic acid by capillary gas chromatography mass spectrometry. 1981 Biomed. Mass Spectrom. pmid:7236862
Meese CO et al. Measurement of thromboxane B2 in human urine by isotope dilution and negative ion chemical ionization mass spectrometry. 1985 Biomed. Mass Spectrom. pmid:2932184
Nocun M et al. French maritime pine bark extract Pycnogenol reduces thromboxane generation in blood from diabetic male rats. 2008 Biomed. Pharmacother. pmid:17698319
Milani M et al. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia. 1996 Biomed. Pharmacother. pmid:8952866
Faure P et al. Influence of a long-term zinc-deficient diet on rat platelet function and fatty acid composition. 1995 Biometals pmid:7865995
Sadovskaia VL et al. [Study of prostaglandins and thromboxanes B2 using mass-spectrometry of secondary ions]. 1986 Bioorg. Khim. pmid:3768052
Vigorita MG et al. Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modelling. 2003 Bioorg. Med. Chem. pmid:12614885
Mayer AM et al. Marine sponge Hymeniacidon sp. amphilectane metabolites potently inhibit rat brain microglia thromboxane B2 generation. 2012 Bioorg. Med. Chem. pmid:22153874
Takeuchi K et al. Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition--I. Synthesis, structure-activity relationship, and evaluation of substituted omega-phenyl-omega-(3-pyridyl)alkenoic acids. 1994 Bioorg. Med. Chem. pmid:7894968
Jiménez-Romero C et al. Dactyloditerpenol acetate, a new prenylbisabolane-type diterpene from Aplysia dactylomela with significant in vitro anti-neuroinflammatory activity. 2014 Bioorg. Med. Chem. Lett. pmid:24279991